WP
RXDX
Woodline Partners’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-317,113
| Closed | -$34M | – | 810 |
|
|
2023
Q1 | $34M | Buy |
317,113
+5,169
| +2% | +$555K | 0.46% | 58 |
|
|
2022
Q4 | $34.3M | Buy |
311,944
+34,207
| +12% | +$3.76M | 0.46% | 47 |
|
|
2022
Q3 | $16.4M | Sell |
277,737
-913,924
| -77% | -$53.9M | 0.23% | 129 |
|
|
2022
Q2 | $33.6M | Buy |
1,191,661
+741,403
| +165% | +$20.9M | 0.52% | 37 |
|
|
2022
Q1 | $17M | Buy |
450,258
+199,932
| +80% | +$7.55M | 0.28% | 113 |
|
|
2021
Q4 | $9.9M | Buy |
250,326
+42,789
| +21% | +$1.69M | 0.14% | 197 |
|
|
2021
Q3 | $4.92M | Buy |
207,537
+4,855
| +2% | +$115K | 0.08% | 251 |
|
|
2021
Q2 | $4.98M | Sell |
202,682
-7,642
| -4% | -$188K | 0.09% | 217 |
|
|
2021
Q1 | $3.84M | Buy |
+210,324
| New | +$3.84M | 0.09% | 218 |
|